MIST

Milestone Pharmaceuticals Inc.

4 catalysts on file

MIST

Milestone Pharmaceuticals Inc.

Approval Confirmed

CARDAMYST

paroxysmal supraventricular tachycardia (PSVT)

326d ago Dec 12, 2025

SEC 8-K verified 4mo ago

MIST

Milestone Pharmaceuticals Inc.

Approval Confirmed

etripamil

paroxysmal supraventricular tachycardia (PSVT)

221d ago Mar 27, 2026

SEC 8-K verified 4mo ago

MIST

Milestone Pharmaceuticals Inc.

Phase 3 AI-extracted

etripamil

atrial fibrillation with rapid ventricular rate (AFib-RVR)

T-minus 239 days ~ Jun 30, 2027

SEC 8-K verified 4mo ago

MIST

Milestone Pharmaceuticals Inc.

PDUFA AI-extracted

etripamil

paroxysmal supraventricular tachycardia (PSVT)

Date TBD Date TBD

SEC 8-K verified 4mo ago